Inayatullah Seema, Phadke Gautam, Vilenski Leonid, Pasya Suresh Kumar, Albrecht Warren
MeritCare Health System, Department of Internal Medicine, University of North Dakota School of Medicine, Fargo, ND, USA.
South Med J. 2010 Jan;103(1):74-5. doi: 10.1097/SMJ.0b013e3181c47dcf.
There is a lack of guidelines regarding the selection of patients who need intravenous heparin, duration of intravenous heparin, and future use of warfarin in prevention and treatment of warfarin-induced skin necrosis. This case report emphasizes the challenges in dealing with vitamin K antagonists (VKA) therapy.